reiterateBILIfinnhub
Citigroup Reiterates Buy Rating on Bilibili Inc. (BILI)
Citigroup reiterated its Buy rating on Bilibili Inc. (NASDAQ:BILI) on October 14, 2026.
Read moreFeatured By
Real-time context
Upgrades, downgrades, initiations, and price-target changes.
Citigroup reiterated its Buy rating on Bilibili Inc. (NASDAQ:BILI) on October 14, 2026.
Read moreStifel reiterated its Buy rating on Manhattan Associates, Inc. (NASDAQ:MANH) on October 14, 2026.
Read moreRBC Capital reiterated its Outperform rating on Ovintiv Inc. (NYSE:OVV) on October 14, 2026.
Read moreWells Fargo reiterated its Overweight rating on Ovintiv Inc. (NYSE:OVV) on October 14, 2026.
Read moreWells Fargo reiterated its Equal-Weight rating on APA Corporation (NASDAQ:APA) on October 14, 2026.
Read moreBarclays reiterated its Equal-Weight rating on Camden Property Trust (NYSE:CPT) on October 14, 2026.
Read moreUBS reiterated its Neutral rating on Camden Property Trust (NYSE:CPT) on October 14, 2026.
Read moreBarclays reiterated its Equal-Weight rating on American Homes 4 Rent (NYSE:AMH) on October 14, 2026.
Read moreJefferies analysts upgraded Texas Roadhouse, Inc. (NASDAQ:TXRH) from Hold to Buy on October 14, 2026.
Read moreBarclays reiterated its Overweight rating on UDR, Inc. (NYSE:UDR) on October 14, 2026.
Read moreUBS reiterated its Buy rating on UDR, Inc. (NYSE:UDR) on October 14, 2026.
Read moreRBC Capital reiterated its Outperform rating on Advanced Drainage Systems, Inc. (NYSE:WMS) on October 14, 2026.
Read moreMorgan Stanley reiterated its Overweight rating on First Solar, Inc. (NASDAQ:FSLR) on October 14, 2026.
Read moreTruist Securities reiterated its Buy rating on Ameren Corporation (NYSE:AEE) on October 14, 2026.
Read moreCantor Fitzgerald reiterated its Overweight rating on M&T Bank Corporation (NYSE:MTB) on October 14, 2026.
Read moreJP Morgan reiterated its Overweight rating on Natera, Inc. (NASDAQ:NTRA) on October 14, 2026.
Read moreHC Wainwright & Co. reiterated its Buy rating on Biomea Fusion, Inc.
Read moreCitizens reiterated its Market Outperform rating on Biomea Fusion, Inc. (NASDAQ:BMEA) on October 14, 2026.
Read moreBTIG reiterated its Buy rating on vTv Therapeutics Inc. (NASDAQ:VTVT) on October 14, 2026.
Read moreBaird analysts downgraded Contineum Therapeutics, Inc. Class A Common Stock (NASDAQ:CTNM) from Outperform to Neutral on October 14, 2026.
Read more